Related references
Note: Only part of the references are listed.Molecular and histopathology directed therapy for advanced bladder cancer
Constantine Alifrangis et al.
NATURE REVIEWS UROLOGY (2019)
Randomized Phase 1 Trial of Pembrolizumab with Sequential Versus Concomitant Stereotactic Body Radiotherapy in Metastatic Urothelial Carcinoma
Nora Sundahl et al.
EUROPEAN UROLOGY (2019)
Pathogenic Germline Variants in 10,389 Adult Cancers
Kuan-lin Huang et al.
CELL (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide
Sebastian Walpole et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Frequent mutation of the FOXA1 untranslated region in prostate cancer
Matti Annala et al.
COMMUNICATIONS BIOLOGY (2018)
BAP1 regulates IP3R3-mediated Ca2+ flux to mitochondria suppressing cell transformation
Angela Bononi et al.
NATURE (2017)
AACR Project GENIE: Powering Precision Medicine through an International Consortium
Fabrice Andre et al.
CANCER DISCOVERY (2017)
Circulating Tumor DNA Reveals Clinically Actionable Somatic Genome of Metastatic Bladder Cancer
Gillian Vandekerkhove et al.
CLINICAL CANCER RESEARCH (2017)
Germline BAP1 mutations induce a Warburg effect
Angela Bononi et al.
CELL DEATH AND DIFFERENTIATION (2017)
Germline Findings in Tumor-Only Sequencing: Points to Consider for Clinicians and Laboratories
Victoria M. Raymond et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Germline Findings in Tumor-Only Sequencing: Points to Consider for Clinicians and Laboratories
Victoria M. Raymond et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
The rules and impact of nonsense-mediated mRNA decay in human cancers
Rik G. H. Lindeboom et al.
NATURE GENETICS (2016)
BAP1 Germline Mutations in Finnish Patients with Uveal Melanoma
Joni A. Turunen et al.
OPHTHALMOLOGY (2016)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): a phase 3, double-blind, randomised, placebo-controlled trial
Lee M. Krug et al.
LANCET ONCOLOGY (2015)
Loss of BAP1 function leads to EZH2-dependent transformation
Lindsay M. LaFave et al.
NATURE MEDICINE (2015)
Tissue-based map of the human proteome
Mathias Uhlen et al.
SCIENCE (2015)
Loss of the deubiquitylase BAP1 alters class I histone deacetylase expression and sensitivity of mesothelioma cells to HDAC inhibitors
Joseph J. Sacco et al.
ONCOTARGET (2015)
Tumor suppressor and deubiquitinase BAP1 promotes DNA double-strand break repair
Helen Yu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Germline BAP1 Mutations Predispose to Renal Cell Carcinomas
Tatiana Popova et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2013)
BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs
Michele Carbone et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
BAP1 loss defines a new class of renal cell carcinoma
Samuel Pena-LlopiS et al.
NATURE GENETICS (2012)
Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers
Mohamed H. Abdel-Rahman et al.
JOURNAL OF MEDICAL GENETICS (2011)
Germline mutations in BAP1 predispose to melanocytic tumors
Thomas Wiesner et al.
NATURE GENETICS (2011)
Germline BAP1 mutations predispose to malignant mesothelioma
Joseph R. Testa et al.
NATURE GENETICS (2011)